Efficacy and safety of retreatment with vedolizumab in patients with ulcerative colitis

被引：0
|
作者：
Sands, B. E. [1 ]
Shafran, I. [2 ]
Farraye, F. A. [3 ]
Cheifetz, A. S. [4 ]
Abhyankar, B. [5 ]
Sankoh, S. [6 ]
Smyth, M. [7 ]
机构：
[1] Mt Sinai Hosp, Icahn Sch Med, Gastroenterol, New York, NY 10029 USA
[2] Shafran Gastroenterol Ctr, Gastroenterol, Winter Pk, FL USA
[3] Boston Med Ctr, Gastroenterol, Boston, MA USA
[4] Beth Israel Deaconess Med Ctr, Med, Boston, MA 02215 USA
[5] Takeda Global Res & Dev Ctr Europe Ltd, Clin Sci, London, England
[6] Takeda Pharmaceut Int Co, Stat, Cambridge, MA USA
[7] Takeda Global Res & Dev Ctr Europe Ltd, Med, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP028
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [41] Subcutaneous vedolizumab for ulcerative colitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 16 - 16
  • [42] Vedolizumab for the treatment of ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (01) : 129 - 135
  • [43] Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
    Peyrin-Biroulet, Laurent
    Arkkila, Perttu
    Armuzzi, Alessandro
    Danese, Silvio
    Ferrante, Marc
    Guardiola, Jordi
    Jahnsen, Jorgen
    Louis, Edouard
    Lukas, Milan
    Reinisch, Walter
    Roblin, Xavier
    Smith, Philip J.
    Kwon, Taek
    Kim, Jeeyoung
    Yoon, Sangwook
    Kim, Dong-Hyeon
    Atreya, Raja
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [44] Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials
    Laurent Peyrin‐Biroulet
    Perttu Arkkila
    Alessandro Armuzzi
    Silvio Danese
    Marc Ferrante
    Jørgen Jordi Guardiola
    Edouard Jahnsen
    Milan Louis
    Walter Lukáš
    Xavier Reinisch
    Philip J Roblin
    Taek Smith
    Jeeyoung Kwon
    Sangwook Kim
    Dong-Hyeon Yoon
    Raja Kim
    BMC Gastroenterology, 24
  • [45] The efficacy and safety of vedolizumab in the treatment of 81 cases of active ulcerative colitis:a single center retrospective study
    唐健
    China Medical Abstracts(Internal Medicine), 2023, 40 (03) : 175 - 176
  • [46] Vedolizumab Long-term Efficacy and Safety in the Treatment of ulcerative Colitis and Crohn's Disease in Adults
    不详
    VISCERAL MEDICINE, 2017, 33 (05) : 391 - 391
  • [47] Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn's Disease and Ulcerative Colitis
    Merza, Nooraldin
    Nawras, Yusuf
    Saab, Omar
    Dahiya, Dushyant Singh
    Ahmed, Zohaib
    Ranabothu, Meghana
    Boujemaa, Safa
    Hassan, Mona
    Kobeissy, Abdallah
    Lilley, Kirthi
    GASTROENTEROLOGY RESEARCH, 2023, 16 (06) : 289 - 306
  • [48] Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario
    Zingone, Fabiana
    Barberio, Brigida
    Compostella, Federico
    Girardin, Giulia
    D'Inca, Renata
    Marinelli, Carla
    Marsilio, Ilaria
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [49] Efficacy and safety of drugs for ulcerative colitis
    Rosenberg, Laura Noddin
    Peppercorn, Mark A.
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (04) : 573 - 592
  • [50] Efficacy and safety of azathioprine treatment in Asian patients with Ulcerative Colitis
    Mao, R.
    Li, Y. -F.
    Chen, B. -L.
    He, Y.
    Zeng, Z. -R.
    Chen, M. -H.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S298 - S298
12345